Omnicell, Inc., headquartered in the United States, is a leading provider of medication management solutions and automation systems for healthcare facilities. Founded in 1992, the company has established itself as a key player in the healthcare technology industry, focusing on optimising pharmacy operations and enhancing patient safety. With a strong presence across North America and expanding operations in international markets, Omnicell offers a range of innovative products, including automated dispensing systems and medication adherence solutions. These offerings are designed to streamline workflows and reduce medication errors, setting Omnicell apart in a competitive landscape. Recognised for its commitment to improving healthcare efficiency, Omnicell has achieved significant milestones, including numerous awards for innovation and excellence in service delivery. As the demand for advanced healthcare solutions continues to grow, Omnicell remains at the forefront, dedicated to transforming medication management for providers and patients alike.
How does Omnicell's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Omnicell's score of 39 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Omnicell reported total carbon emissions of approximately 5,245,000 kg CO2e, comprising 335,000 kg CO2e from Scope 1 and 4,910,000 kg CO2e from Scope 2 emissions. This represents a slight decrease from 2023, where total emissions were about 5,542,000 kg CO2e, with Scope 1 emissions at 392,000 kg CO2e and Scope 2 emissions at 5,149,000 kg CO2e. Over the past few years, Omnicell's emissions have shown fluctuations, with 2022 emissions recorded at approximately 6,387,000 kg CO2e, including 475,000 kg CO2e from Scope 1 and 5,912,000 kg CO2e from Scope 2. The company has not disclosed any Scope 3 emissions data, indicating a focus on direct and indirect emissions from their operations and energy use. Despite the lack of specific reduction targets or initiatives outlined in their reports, Omnicell continues to monitor and report its emissions, reflecting a commitment to transparency in its climate impact. The company’s emissions intensity ratio for 2024 stands at about 4.72 kg CO2e per million USD of revenue, indicating a proactive approach to managing its carbon footprint relative to its financial performance.
Access structured emissions data, company-specific emission factors, and source documents
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Scope 1 | 229,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
Scope 2 | 9,252,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | - | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Omnicell is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.